Literature DB >> 10954207

Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers.

A Schmidtchen1.   

Abstract

It has been proposed that excessive and uncontrolled proteolytic activity is an important pathogenetic factor for chronic wounds. Identification of molecules that either control or reflect proteolysis in wounds may prove to be useful in determining wound healing activity. In this study wound fluid was sampled under a polyurethane dressing or on hydrophilic glass filters. Multiple chronic wound fluid components were identified; viz. the previously described alpha2-macroglobulin, alpha1-antitrypsin and fibronectin, as well as "novel" wound fluid molecules such as complement factor C3, inter-alpha-inhibitor, kininogen, IgG, IgA, C-reactive protein, tetranectin, orosomucoid and ceruloplasmin. There appeared to be a highly variable degradation of alpha1-antitrypsin in the wounds; furthermore, the activation of C3 appeared to correlate with the appearance of fibronectin breakdown products. In wound fluid, inter-alpha-inhibitor was degraded. The influence of the sampling procedures was studied. It was shown that contact phase activation must be taken into account in the study of molecules (such as kininogens) activated by hydrophilic charged surfaces.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954207     DOI: 10.1080/000155500750042925

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  15 in total

1.  Proteolytic activation transforms heparin cofactor II into a host defense molecule.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Douglas M Tollefsen; Martin Malmsten; Matthias Mörgelin; Artur Schmidtchen
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

2.  A pre-clinical functional assessment of an acellular scaffold intended for the treatment of hard-to-heal wounds.

Authors:  Gary K Shooter; Derek R Van Lonkhuyzen; Tristan I Croll; Yang Cao; Yan Xie; James A Broadbent; Dario Stupar; Emily C Lynam; Zee Upton
Journal:  Int Wound J       Date:  2013-04-05       Impact factor: 3.315

3.  Antimicrobial effects of helix D-derived peptides of human antithrombin III.

Authors:  Praveen Papareddy; Martina Kalle; Ravi K V Bhongir; Matthias Mörgelin; Martin Malmsten; Artur Schmidtchen
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

4.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

5.  Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism.

Authors:  Jitka Petrlova; Finja C Hansen; Mariena J A van der Plas; Roland G Huber; Matthias Mörgelin; Martin Malmsten; Peter J Bond; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-04       Impact factor: 11.205

6.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

Review 7.  Protease activity as a prognostic factor for wound healing in venous leg ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Nikki Stubbs; Gill Norman; Jason Kf Wong; Nicky Cullum; Richard D Riley
Journal:  Cochrane Database Syst Rev       Date:  2018-09-01

8.  Superficial wound swabbing: a novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations.

Authors:  Michael Schmohl; Stefan Beckert; Thomas O Joos; Alfred Königsrainer; Nicole Schneiderhan-Marra; Markus W Löffler
Journal:  Diabetes Care       Date:  2012-07-26       Impact factor: 19.112

Review 9.  Complement activation and inhibition in wound healing.

Authors:  Gwendolyn Cazander; Gerrolt N Jukema; Peter H Nibbering
Journal:  Clin Dev Immunol       Date:  2012-12-30

10.  Histidine-rich glycoprotein protects from systemic Candida infection.

Authors:  Victoria Rydengård; Oonagh Shannon; Katarina Lundqvist; Lukasz Kacprzyk; Anna Chalupka; Anna-Karin Olsson; Matthias Mörgelin; Willi Jahnen-Dechent; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2008-08-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.